Acadia Pharmaceuticals Inc’s filing revealed that its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $18670.0 on Mar
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Acadia Pharmaceuticals Inc’s recent filing unveils that its Director GAROFALO ELIZABETH A. unloaded Company’s shares for reported $89673.0 on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Acadia Pharmaceuticals Inc revealed its Director GAROFALO ELIZABETH A. unloaded Company’s shares for reported $89673.0 on Mar
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Acadia Pharmaceuticals Inc’s recent filing unveils that its Director GAROFALO ELIZABETH A. unloaded Company’s shares for reported $89673.0 on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Acadia Pharmaceuticals Inc’s recently made public that its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $9481.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Acadia Pharmaceuticals
